- Home
- NRXP vs JSPR Comparison
NRXP vs JSPR Comparison
Compare NRXP & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | JSPR |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 68.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRXP | JSPR |
|---|---|---|
| Price | $2.11 | $1.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | ★ $30.50 | $25.60 |
| AVG Volume (30 Days) | 455.8K | ★ 3.8M |
| Earning Date | 11-17-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $242,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $643.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.15 | $1.39 |
| 52 Week High | $6.01 | $23.37 |
Technical Indicators
Market Signals| Indicator | NRXP | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 38.16 | 47.87 |
| Support Level | $2.22 | $1.60 |
| Resistance Level | $2.39 | $1.93 |
| Average True Range (ATR) | 0.15 | 0.20 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 2.27 | 40.30 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.